 |
 |
 |
 |
 |
 |
  |
Board of Directors Andrew Sandham, (Chairman) |
LeadershipManagement Team |
David Brand Mr Brand was most recently President and CEO of Cardiokine, Inc., where he led strategic and organizational development, multiple private financings and most recently a significant co-development and commercialization agreement with Biogen Idec. Prior to joining Cardiokine, Mr. Brand headed up the CNS, Metabolic, Anti-infective and Cardiovascular Business Units at GSK where he led the launches of Paxil, Requip, Avandia and Avandia extensions, and the pre-launch/development activities for Coreg, Hycamtin, Kytril and Augmentin ES/XR. Mr. Brand holds a Bachelor of Commerce degree from Concordia University. He also serves on the Board of Directors at InteKrin Therapeutics, Inc. |
|